People
Naoya Sato
Naoya Sato formerly served as Director of MP Healthcare Venture Management from March 2015 to March 2019 according to his own public professional chronology. Kauffman Fellows’ primary Laura Tadvalkar biography independently identifies him as her MPH Director mentor. His earlier pharmaceutical research and management work included Mitsubishi Tanabe Pharma and Tanabe Research Laboratories USA, with autoimmune, psychiatric and neurological research using human induced pluripotent stem cells. His public profile subsequently identifies business-development work at Mitsubishi Tanabe Pharma, academic research-administration work at Chiba University from April 2023 to February 2026, and Chief Operating Officer of TOKIWA-Bio from March 2026. This is a historical MPH role, not an assertion of current employment; month-only dates remain unconverted to invented days.
Roles
Former Director (March 2015–March 2019)